rdcu.be/et8aj
This new Review discusses emerging Hippo pathway-targeted therapies for cancer, particularly those that target TEAD DNA binding proteins and their interaction with the YAP/TAZ transcription co-activators
rdcu.be/et8aj
This new Review discusses emerging Hippo pathway-targeted therapies for cancer, particularly those that target TEAD DNA binding proteins and their interaction with the YAP/TAZ transcription co-activators
Big thanks to co-author Tracy Tang from Vivace Therapeutics. #TEADinhibitors
rdcu.be/et2NL
Big thanks to co-author Tracy Tang from Vivace Therapeutics. #TEADinhibitors
rdcu.be/et2NL